The price of TPST is predicted to go up -15.3%, based on the high correlation periods with KALU. The similarity of these two price pattern on the periods is 96.98%.

TPST

KALU

Down: -15.3%Similarity: 96.98%

TPST Revenue Forecast

TPST EPS Forecast

TPST FAQs

What is bull’s view on TPST?

TPST stock is currently trading at $1.36, reflecting a slight increase of 1.41% on the Nasdaq. Bulls may argue that the extension of the stockholder rights plan aims to protect long-term value and prevent hostile takeovers, which could stabilize the stock. Analysts like HC Wainwright & Co. maintain a strong buy rating with a $47 target, suggesting significant upside potential if the company successfully advances its drug pipeline.

What is bear's view on TPST?

TPST stock is currently trading at $1.36, reflecting a slight increase of 1.41% recently. However, the bearish view stems from its high-risk profile, as the company has faced significant challenges in advancing its drug pipeline, with limited clinical success and reliance on speculative outcomes. Additionally, the stock's low price and volatility suggest caution, as it may struggle to sustain long-term value without clear progress in its trials.